Login / Signup

Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.

ChangDong LinYue LiYuebin ZhangZhaoYuan LiuXia MuChenjian GuJing LiuYutang LiGuoHui LiJianFeng Chen
Published in: Signal transduction and targeted therapy (2021)
Keyphrases
  • angiotensin ii
  • angiotensin converting enzyme
  • protein protein
  • respiratory syndrome coronavirus
  • human health
  • binding protein
  • adverse drug
  • drug induced
  • risk assessment
  • coronavirus disease